Agenus announces agenus insights - virtual r&d miniseries

Lexington, mass., feb. 09, 2021 (globe newswire) -- agenus inc. (nasdaq: agen), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that it will host its inaugural agenus insights on “optimally targeting tigit” on thursday, february 11, 2021 at 1:00 p.m. et.
AGEN Ratings Summary
AGEN Quant Ranking